PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
03-Jun-2020 Sarclisa® (isatuximab) approved for the treatment of relapsed/refractory multiple myeloma in the EU1 Sanofi
03-Jun-2020 Helsinn Group announces FDA approval of a new liquid formulation of AKYNZEO® (fosnetupitant/palonosetron) injection in the United States Lugano
03-Jun-2020 The Holistic Reports “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020 The Holistic Report
03-Jun-2020 WORLD MEDICAL COMPOSITES MARKET By Fiber Type Overview And Forecast, 2018-2025. theholisticreports.
03-Jun-2020 Orgenesis to collaborate with The Edith Wolfson Medical Center to conduct clinical study using Orgenesis’ proprietary POCare technologies for the generation and expansion of Tumor Infiltrating Lymphocytes Orgenesis Inc
03-Jun-2020 Sanofi to present oncology strategy, provide update on portfolio and emerging pipeline Sanofi
03-Jun-2020 AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ™ (upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis AbbVie
03-Jun-2020 ASCO 2020: UK-first study shows feasibility of genetic screening for prostate cancer The Institute of Cancer Research
03-Jun-2020 Sanofi to launch “Action 2020”, a worldwide employee stock purchase plan Sanofi
03-Jun-2020 New First-in-Class Phase 3 TREMFYA®▼ (guselkumab) Data Demonstrate Improvement in Psoriatic Arthritis Joint and Skin Symptoms at Week 52 Janssen
03-Jun-2020 ERT Survey Indicates Swift Adoption of Virtual Clinical Trials Due to COVID-19 ERT
03-Jun-2020 UCB and N-SIDE increase their strategic collaboration N-SIDE
03-Jun-2020 Clinerion gains ISO/IEC 15504 (SPICE) certification. Clinerion Ltd.
02-Jun-2020 Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19 Gilead
02-Jun-2020 Lilly Begins World’s First Study of a Potential COVID-19 Antibody Treatment in Humans Eli Lilly and Company
01-Jun-2020 Sanifit Enhances Leadership Team with New Executive Appointments Sanifit
01-Jun-2020 Acacia Pharma Announces Debt for Equity Swap with Cosmo Pharmaceuticals Acacia Pharma Group plc
01-Jun-2020 MATINS Update - Safety and efficacy results from Part I of MATINS study presented in poster at ASCO20 Virtual - Patient recruitment for Part II in multiple cohorts progressing well Faron Pharmaceuticals Ltd
01-Jun-2020 MATINS Update - Safety and efficacy results from Part I of MATINS study presented in poster at ASCO20 Virtual - Patient recruitment for Part II in multiple cohorts progressing well Faron Pharmaceuticals Ltd
01-Jun-2020 MATINS Update - Safety and efficacy results from Part I of MATINS study presented in poster at ASCO20 Virtual - Patient recruitment for Part II in multiple cohorts progressing well Faron Pharmaceuticals Ltd